Articles On Rhinomed (ASX:RNO)

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

Rhinomed’s (RNO) interim results for its trial on respiratory virus diagnosis reveal the Rhinoswab Junior is an “overwhelmingly preferred” solution The trial investigated the diagnosis of respiratory viruses in children using the Rhinoswab...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product sales estimated at $230 million. And medical cannabis prescriptions are at an all-time high. The TGA said 13,666 Australian patients were app...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The ASX lost ground on Wednesday, as the banks struggled and the US dollar strengthened as markets continue to assess the prospect of tighter monetary policy and its potential effect on asset prices. Commonwealth Bank (ASX:CBA) tanked in th...

Instead of a chocolate advent calendar this year, Californians can get their hands on a cannabis calendar with edibles, prerolls, grams of flower and four days of cannabis accessories. “We’ve seen the success of unique advent calendars in o...

The ASX started the week on a downward note with tech leading the laggards despite one of Australia’s major unicorns joining the bourse and gaining over 30%. SiteMinder (ASX:SDR), a hotel commerce platform, listed on the ASX at $5.06 per sh...

Wearable nasal and respiratory company Rhinomed (RNO) has received ethics approval to undertake a clinical trial of Rhinoswab at St Vincents Hospital in Melbourne This trial will build on the existing data that confirms Rhinoswab is a supe...

The ASX got off to a solid start today but the rally eased following the release of inflation data. Core inflation rose at the fastest pace since 2015 leading to speculation that the tightening of monetary policy could come sooner than 2024...

Wearable nasal and respiratory technology company Rhinomed (ASX:RNO) says it is continuing to generate data that supports the Rhinoswab as the preferred sampling method for the diagnosis of upper respiratory disease.

Actor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s cannabis industry ahead of a Blues Brothers performance. “We believe that cannabis is one of the great, great medicines that can lead to a path...

It’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher than yesterday, closing at 7,362 which marked a 3 week high but is still 3.5% above the all time high reached in mid-August. Travel stocks gai...

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

The COVID-19 outbreaks in NSW and Victoria have led to a surge in demand for testing, and that trend looks set to show up in the bottom line of pathology network Australian Clinical Labs (ASX:ACL). Australian Clinical Labs, which listed in...

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

Australia’s bourse had its biggest decline since February 26 falling by over 2%. The ASX 200 fell 2.1% to close at 7,248 and is down 5% since August 13. The ASX Emerging Companies Index fared worse, losing over 4% in its worst day since Apr...

Wearable nasal and respiratory technology company Rhinomed (ASX:RNO) has received an initial purchase order for one million Rhinoswabs from the Victorian Department of Health to support the state's testing capability.

The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing. The post Rhinomed Share Price Surges 20% on Government Deal (ASX:RN...

The company is continuing to scale-up its manufacturing capabilities to accommodate growing domestic and international demand for this innovative technology.

The Rhinomed Ltd (ASX: RNO) share price is on the move during mid-morning trade. This comes after the medical device company provided the market with a positive release in regards to its Rhinoswab product. At the time of writing, Rhinomed...

Shares in drug company Noxopharm (ASX:NOX) climbed by around 4% this morning following the release of the company’s annual report. Along with the numbers, NOX also detailed the ongoing clinical development of Veyonda (idronoxil) as an adjuv...

Highlights The ASX 200 was trading 7 points up at 7,376.5 during opening trade. The market breadth has been on a positive side so far, with 10 out of the 11 sectors trading in the green. New Energy Solar announced that its off-market...

Victoria has followed New South Wales with an order for 1 million of Rhiomed’s (ASX:RNO) Rhinoswab, leading to another price surge for the ASX medtech stock. The Rhinoswab technology aims to improve the sample collection process for PCR tes...

Shares in wearable nasal and respiratory technology company Rhinomed (ASX: RNO) are up more than 18 per cent this morning after the company announced Victoria has ordered 1 million of the group’s nasal swabs to support the State’s testing p...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Rhinomed has created the world’s first nasal swab designed specifically for children — The Rhinoswab Junior Ethics approval has been received for a clinical trial to commence with the Murdoch Children’s Research Institute (MCRI) at The Ro...

August was another month of lockdown for much of Australia’s East Coast but lockdowns and even a 2% drop in the middle of the month couldn’t stop the ASX from producing another winners list. The ASX 200 ultimately finished August 1.9% highe...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Hot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger companies near the top end of the list as investors responded to some reporting season surprises. Each week, Stockhead recaps ASX stocks that are...

The ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday. The ASX Emerging Companies Index lost 0.57% to close at 2,285 points. The best sector was industrials which gained 1.07%. Tech and consume...

The Rhinomed Ltd (ASX: RNO) share price is racing into uncharted territory today. This comes after the medical device company announced it has completed development of a nasal swab designed for children. The news sent Rhinomed shares flyin...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c...

Highlights  ASX-listed healthcare companies rarely fail to bring joy to the market participants, with a few of them providing outstanding returns in the last couple of months. Rhinomed, IDT Australia, and Prescient lead the way with ou...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Summary When a global crisis happens, investors often move towards safe haven assets such as gold, which acts as a catalyst for the business of gold miners. During a lockdown, owning high-quality blue-chip stocks is generally a good id...

Summary Rhinomed shares closed yesterday’s trading session on a high, delivering a 50% jump on the previous close. The medical device company has seen a massive rise of ~135% in the share price since the turn of the year. The latest s...

Rhinomed (ASX:RNO), a company working on wearable nasal and respiratory technology, says it has received purchase orders and begun supplying NSW Health Pathology with an initial one million Rhinoswabs.

Asian stocks lacked direction today as investors are keenly waiting for US inflation data. The Nikkei 225 in Tokyo was up close to 1% to 28,069.28 and the Shanghai Composite Index was trading flat at 3,532.23. The Kospi in South Korea was d...

While COVID-19 continues to wreck havoc across NSW, the ASX remained in a state of zen on Wednesday, as local stocks eased to new record highs. The ASX 200 finished around 0.3% higher to close at 7,584, outpaced by the microcap Emerging Com...

While COVID-19 continues to wreck havoc across NSW, the ASX remained in a state of zen on Wednesday, as local stocks eased to new record highs. The ASX 200 finished around 0.3% higher to close at 7,584, outpaced by the microcap Emerging Com...

Shares in Rhinomed (ASX: RNO) have charged 82 per cent higher today after the wearable nasal and respiratory technology company received purchase orders from the NSW Government for its patented, self-administered nasal swabs. The group ha...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.4% to 7,590.8 points. Four ASX shares that are climbing more than most today are listed below...

The Rhinomed Ltd (ASX: RNO) share price is rocketing higher on Wednesday. In morning trade, the medical device company’s shares are up a massive 90% to a 52-week high of 38 cents. This means the Rhinomed share price is now up approximately...

The ASX closed today at a new record high. The ASX 200 closed at 7,563 points, 0.32% higher than yesterday. The best sector was tech which gained over 1.5%, while industrials retreated over 1%. The rise of the market came despite NSW reachi...

Despite a solid start to the day the ASX closed Monday at the same point it closed on Friday. After gaining as much as 0.3% by 11am the ASX 200 closed flat at 7,538 points. The ASX Emerging Companies Index finished slightly higher, by 0.03%...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...